“Pharma executives are under intense pressure to compete with innovative new technologies in a rapidly shifting market, driving greater efficiency and returns on investment. Artificial Intelligence, with its potential for big data and predictive analytics, has become a central focus in this move towards efficiency in pharma. However, recent high-profile data breaches have made it painfully clear that successful adoption of AI-powered analytics must take customer trust into careful consideration.”
Did this report add value to you? We are currently developing our 2019 thought leadership series.
Please do let us know your feedback.
